catalan institute of oncology

Catalonia has established a reputation as a global centre of scientific excellence, pioneering research and innovative ideas. This corner of Europe, with just 0.1% of the world’s population, accounts for nearly 1% of global scientific production. The Catalan Research system, formed of 12 internationally esteemed universities, over 60 research centres, 15 world class hospitals, and almost 9,000 innovative companies, attests to the Catalonia's ambitions in science. This territory is also a magnet of international funding: with 1.5% of Europe’s population, it receives 2.2% of European competitive funds and 3.5% of European Research Council (ERC) grants. There can be no doubt that Catalonia is now a benchmark in Southern Europe, producing frontier research and punching considerably above its weight in terms of scientific contribution.  It is attracting worldwide talent and projects, and many consider it to be fast becoming the Palo Alto of biomedical research.

The Catalan Institute of Oncology (ICO) and Roche pharmaceutical company have signed an agreement stating that the Catalan public institute will pay for treatments against cancer depending on clinical results adapted to each specific patient. For now, the agreement provides that Roche will supply two drugs against the most common cancers, mostly breast and colon. According to the agreement, the probabilities of success will be thoroughly examined and if they meet the requirements, the Catalan Government will fully pay for the treatment. If not, Roche will assume the costs progressively according to the degree of success.

The Catalan Institute of Oncology (ICO) has introduced a world pioneering technique which allows four out of five patients who cannot undergo surgery to survive the illness. This technique causes less after-effects than the traditional radiotherapy. Furthermore, statistics show that with the regular treatment, two thirds of these patients die. However, Ferran Gadea, the Head of the Radiotherapy and Oncology Service, says that the best option to cure a lung cancer is still to undergo the operation when possible.

Researchers from the Catalan Institute of Oncology have led the largest international study on breast cance4r and nutrition. The 8-year study has been based on 335,062 women between 35 and 70 years old. It has involved 23 centres in 10 European countries and it has been published in the ‘International Journal of Cancer’. The study concludes that the Mediterranean diet can reduce the risk of breast cancer by 6% among women in general and 7% in the case of post-menopausal patients.

The centre received the ‘Gold Level Award’ from the Global Network for Tobacco Health Care Services, thanks to its fight against the effects of smoking. The jury emphasised the training given to both hospital workers and patients in order to give up smoking and the achievement of a strict non-smoking area in this health centre’s facilities. Only ten hospitals around the world have this distinction, among them another Catalan institution: Sant Joan de Déu Hospital in Manresa, in Central Catalonia.

The last ‘SCImago Institutions Ranking’ classified the 3,000 best research institutions in the world. Harvard University tops the ranking, but the Catalan institute, is ranked second in Spain and among the best European research centres. Catalonia, and in particular Barcelona is consolidating its position as a biomedical science centre at international level.

Catalan researchers participated in an international study which analysed of more than 20,000 women from various countries. They have found that using intrauterine contraceptive devices (IUD) reduces the risk to suffer cervical cancer by half.

An international study led by a Catalan team of researchers finds that the vaccine is not only effective in women between the ages of 9 and 26 , but in women older than 26. Women up to 45 years old could use this preventative vaccine. The study is published this Wednesday in the ‘British Journal of Cancer’.

A new technique has been put into place that enables more precise irradiations, affecting surrounding organs less and thus minimising secondary effects. The Catalan monographic hospital is the 2nd in Spain to use this technique.